(Q54122400)

English

In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

Moraxella catarrhalis

object named as

Moraxella catarrhalis

1 reference

based on heuristic

inferred from title

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

1

object named as

Jones RN

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

author name string

Biedenbach DJ

2

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

Croco MA

3

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

Barrett MS

4

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

31

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

4

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

573-578

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Is Haemophilus influenzae finished?

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of a new cephalosporin ME-1206 compared with other agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antibacterial activity of ME1207, a new oral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900044-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(98)00044-3

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9764398

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54122400&oldid=1940470205"